DailyBubble News
DailyBubble News

Sapiens Accelerates Growth for Medical Professional Liability Insurers

Sapiens International Corporation, a global leader in insurance software solutions, has announced a strategic investment in Sapiens CoreSuite for Medical Professional Liability (MPL) to support growth and innovation in the MPL industry. By enhancing its MPL capabilities and products, including policy administration and claims management, Sapiens aims to meet the needs of MPL insurers in a rapidly evolving market.

This expansion marks a significant milestone for Sapiens, strengthening support for existing MPL customers and reaching out to new prospects seeking industry best practices. The advanced, integrated solution offered by Sapiens empowers insurers to effectively manage MPL operations and quickly adapt to regulatory requirements. With improved functionality and flexibility, Sapiens CoreSuite for MPL delivers substantial business value, supporting growth and retention for insurers.

For MPL insurers and their customers, ease of integration is crucial. Cloud-based solutions with AI-driven automation have become standard, allowing for smooth implementation and seamless integration between vendors. Sapiens’ role as a leader in the MPL ecosystem is underscored by its commitment to ongoing strategic focus in the market.

Sapiens CoreSuite for Medical Professional Liability is designed specifically to address the complex processing needs of the MPL market. The end-to-end insurance solution supports individuals, groups, hospitals, and institutional businesses throughout the policy lifecycle.

Sapiens International Corporation is dedicated to empowering insurers with intelligent software solutions, leveraging AI and automation to ensure operational excellence in a rapidly changing marketplace. With a global presence and a focus on customer-driven partnerships, Sapiens continues to innovate to support its customers’ success.

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x